Abraxane, an albumin-bound paclitaxel nanoparticle formulation, is superior to standard paclitaxel preparations as a result of it has higher efficacy towards unresectable pancreatic most cancers. Earlier stories recommend that this higher efficacy of Abraxane than typical paclitaxel preparation might be attributable to its transport via Gp60, an albumin receptor on the floor of vascular endothelial cells. The elevated tumor accumulation of Abraxane can also be brought on by the secreted protein acid and wealthy in cysteine within the tumor stroma. Nonetheless, the uptake mechanism of Abraxane stays poorly understood.
On this examine, we demonstrated that the supply of Abraxane occurred by way of completely different receptor pathways from that of endogenous albumin. Our outcomes confirmed that the uptake of endogenous albumin was inhibited by a Gp60 pathway inhibitor within the strategy of endocytosis via endothelial cells or tumor cells. In distinction, the uptake of Abraxane-derived HSA was much less affected by the Gp60 pathway inhibitor however considerably diminished by denatured albumin receptor inhibitors. In conclusion, these information point out that Abraxane-derived HSA was taken up into endothelial cells or tumor cells by a mechanism completely different from regular endogenous albumin.
These new information on distinct mobile transport pathways of denatured albumin by way of gp household proteins completely different from these of innate albumin make clear the mechanisms of tumor supply and antitumor exercise of Abraxane and supply new scientific rationale for the event of a novel albumin drug supply technique by way of a denatured albumin receptor.
Pancreatic adenocarcinoma (PA) is a really aggressive most cancers and has one of many poorest prognoses. Often, the prognosis is late and resistant to standard remedy. Environmental and genetic elements contribute to the etiology, equivalent to tobacco and alcohol consumption, power pancreatitis, diabetes and weight problems. Somatic mutation in pancreatic most cancers cells are recognized and SNP profile by GWAS may entry novel genetic threat elements for this illness in several inhabitants context.
9 SNPs had been nominally related to pancreatic adenocarcinoma threat, with 5 of the minor alleles conferring protecting impact whereas four associated as threat issue. In epidemiological and medical information, tobacco smoking, diabetes and pancreatitis historical past had been considerably associated to pancreatic adenocarcinoma threat. Polygenic threat scores computed utilizing the SNPs within the examine confirmed robust associations with PA threat.
Danger of most cancers in sufferers with recurrent aphthous stomatitis in Korea: A nationwide population-based examine
The connection between recurrent aphthous stomatitis (RAS), a typical mucosal lesion, and most cancers has not been demonstrated. This examine investigated the danger for creating most cancers in sufferers with RAS, primarily based on information from Korea’s Nationwide Well being Insurance coverage Sharing Service (NHISS). Nationwide population-based cohort information from 2005 to 2009 offered by the NHISS was used. The group recognized with RAS for five years and an undiagnosed management group had been constructed via 1:1 propensity rating matching (PSM). The experimental design in contrast the incidence price of a most cancers prognosis from 2010 to 2015 between these 2 teams.
After figuring out 13,808 folks that met our inclusion criterion from a 1 million cohort group, 13,808 controls had been included within the examine via PSM. Amongst all cancers, pancreatic most cancers had an adjusted hazard ratio of 1.26. For the remainder of the cancers, there was no important incidence price. RAS was related to an elevated threat of pancreatic most cancers within the evaluation utilizing giant population-based cohort information. Additional long-term follow-up research are wanted. Endoscopic ultrasonography-guided tissue acquisition (EUS-TA) has change into the norm for the prognosis of pancreatic strong lesions.
EUS-TA is comparatively protected, however varied issues can happen. Contaminated pancreatic necrosis (IPN) is a uncommon however severe complication. The most recent pointers recommend that every one invasive interventions in sufferers with IPN must be delayed till walled-off necrosis seems. A 73-year-old man was referred to our hospital with double major cancers together with gallbladder and pancreas. We carried out EUS-TA on metastatic pancreatic tail most cancers to verify histologic prognosis. Six days after the process, he developed belly ache and fever.
Anti-tumoral exercise of the Pan-HER (Sym013) antibody combination in gemcitabine-resistant pancreatic most cancers fashions
Chemoresistance, significantly to gemcitabine, is a significant problem in pancreatic most cancers. The epidermal progress issue receptor and human epidermal progress issue receptors 2 and three are expressed in lots of tumors, and they’re related therapeutic targets attributable to their synergistic interplay to advertise tumor aggressiveness and therapeutic resistance. Cocktails of antibodies directed towards completely different targets are a promising technique to beat these processes. Right here, we discovered by immunohistochemistry that these three receptors had been co-expressed in 11% of sufferers with pancreatic adenocarcinoma.
We then developed gemcitabine-resistant pancreatic most cancers cell fashions and one patient-derived xenograft by successive publicity to growing doses of gemcitabine. We confirmed that expression of EGFR, HER2 and HER3 was elevated in these gemcitabine-resistant pancreatic most cancers fashions, and that an antibody combination towards all three receptors inhibited tumor progress in mice and downregulated HER receptors. Lastly, we demonstrated that the Pan-HER and gemcitabine mixture has an additive impact in vitro and in mice xenografted with the gemcitabine-sensitive or resistant pancreatic fashions.
Human Carbohydrate Antigen 72-4 (CA72-4) ELISA Kit |
RDR-CA72-4-Hu-48Tests |
Reddot Biotech |
48 Tests |
EUR 600 |
Human Carbohydrate Antigen 72-4 (CA72-4) ELISA Kit |
RDR-CA72-4-Hu-96Tests |
Reddot Biotech |
96 Tests |
EUR 830.4 |
Gastrointestinal Cancer Antigen (CA 19-9), antigen grade |
CA1991-N-10 |
Alpha Diagnostics |
10 KU |
EUR 634.8 |
BSA (Standard Grade) |
30-AB70 |
Fitzgerald |
1 kg |
EUR 1078.8 |
Description: Standard Grade Bovine Serum Albumin (99% pure) |
Inactivated RuV Grade 4 Antigen |
VAng-Lsx0477-1mg |
Creative Biolabs |
1 mg |
EUR 3696 |
Description: RuV Grade 4, natural antigen. |
Carbohydrate Antigen 72-4 (CA72-4) Antibody |
20-abx102717 |
Abbexa |
-
EUR 477.60
-
EUR 159.60
-
EUR 1328.40
-
EUR 644.40
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Carbohydrate Antigen 72-4 (CA72-4) Antibody |
abx023799-1mg |
Abbexa |
1 mg |
EUR 1387.2 |
|
Carbohydrate Antigen 72-4 (CA72-4) Antibody |
abx023800-1mg |
Abbexa |
1 mg |
EUR 1387.2 |
|
Carbohydrate Antigen 72-4 (CA72-4) Antibody |
abx023801-1mg |
Abbexa |
1 mg |
EUR 1387.2 |
|
Carbohydrate Antigen 72-4 (CA72-4) Antibody (Biotin) |
20-abx272556 |
Abbexa |
-
EUR 510.00
-
EUR 276.00
-
EUR 1429.20
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
ExoStd? Lyophilized Exosome Standard (30 µg, Human Plasma, 4 vials) |
M1040-4 |
Biovision |
|
EUR 1090.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, Human Plasma, 4 vials) |
M1041-4 |
Biovision |
|
EUR 1364.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, Human Serum, 4 vials) |
M1042-4 |
Biovision |
|
EUR 1090.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, Human Serum, 4 vials) |
M1043-4 |
Biovision |
|
EUR 1358.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, Human Urine, 4 vials) |
M1044-4 |
Biovision |
|
EUR 1090.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, Human Urine, 4 vials) |
M1045-4 |
Biovision |
|
EUR 1364.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, Human Saliva, 4 vials) |
M1046-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, Human Saliva, 4 vials) |
M1047-4 |
Biovision |
|
EUR 1364.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, U87 MG, 4 vials) |
M1054-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, U87 MG, 4 vials) |
M1055-4 |
Biovision |
|
EUR 1370.4 |
Lyophilized recombinant standard |
ST0000-4 |
BosterBio |
4ng/vial |
EUR 206.4 |
Proteinase K, Recombinant, Standard Grade |
9250-100 |
Biovision |
|
EUR 124.8 |
Proteinase K, Recombinant, Standard Grade |
9250-10G |
Biovision |
|
EUR 4627.2 |
Proteinase K, Recombinant, Standard Grade |
9250-1G |
Biovision |
|
EUR 548.4 |
Proteinase K, Recombinant, Standard Grade |
9250-500 |
Biovision |
|
EUR 314.4 |
Proteinase K, Recombinant, Standard Grade |
9251-100 |
Biovision |
|
EUR 1266 |
Proteinase K, Recombinant, Standard Grade |
9251-25 |
Biovision |
|
EUR 352.8 |
Proteinase K, Recombinant, Standard Grade |
9251-5 |
Biovision |
|
EUR 144 |
Cancer Antigen 242 Antigen |
VAng-Cr3876-10kU |
Creative Biolabs |
10 kU |
EUR 505.2 |
Description: Cancer Antigen 242 Antigen, Host/Source: Metastatic Liver. The purity is detected by gel filtration. |
Cancer Antigen 50 Antigen |
VAng-Cr3877-50kU |
Creative Biolabs |
50 kU |
EUR 6642 |
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
Human Carbohydrate Antigen 72-4 (CA72-4) ELISA Kit |
abx572074-96tests |
Abbexa |
96 tests |
EUR 943.2 |
|
Human carbonhydrate antigen 72-4 (CA72-4) ELISA kit |
CSB-E09411h-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Human carbonhydrate antigen 72-4 (CA72-4) in samples from serum, plasma, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human carbonhydrate antigen 72-4 (CA72-4) ELISA kit |
1-CSB-E09411h |
Cusabio |
-
EUR 1080.00
-
EUR 6571.20
-
EUR 3480.00
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human carbonhydrate antigen 72-4 (CA72-4) in samples from serum, plasma, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
ExoStd? Lyophilized Exosome Standard (30 µg, COLO1 cell line, 4 vials) |
M1048-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, COLO1 cell line, 4 vials) |
M1049-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, MM1 cell line, 4 vials) |
M1050-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, MM1 cell line, 4 vials) |
M1051-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, BLCL21 cell line, 4 vials) |
M1052-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, BLCL21 cell line, 4 vials) |
M1053-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, HCT116 cell line, 4 vials) |
M1058-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, HCT116 cell line, 4 vials) |
M1059-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, PC3 cell line, 4 vials) |
M1060-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, PC3 cell line, 4 vials) |
M1061-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, DAUD1 cell line, 4 vials) |
M1064-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, DAUD1 cell line, 4 vials) |
M1065-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, A549 cell line, 4 vials) |
M1066-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, A549 cell line, 4 vials) |
M1067-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, B16F10 cell line, 4 vials) |
M1070-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, B16F10 cell line, 4 vials) |
M1071-4 |
Biovision |
|
EUR 1370.4 |
Polystyrene Particle Size Standard |
PPS-4 |
Spherotech |
mL |
EUR 157.2 |
Description: Please reffer to the technical data sheet for more detail information for this item. Our dedicated team would be happy to assist you via live chat, email or phone. |
ExoStd? Lyophilized Exosome Standard (30 µg, BPH-1 cell line, 4 vials) |
M1062-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, BPH-1 cell line, 4 vials) |
M1063-4 |
Biovision |
|
EUR 1370.4 |
ExoStd? Lyophilized Exosome Standard (30 µg, K-562 cell line, 4 vials) |
M1068-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, K-562 cell line, 4 vials) |
M1069-4 |
Biovision |
|
EUR 1370.4 |
Inactivated RuV Grade 4 Antigen (Strain HPV-77) |
VAng-0638Lsx-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: RuV (Strain HPV-77) Grade 4 antigen, inactivated by UV and verified by infectivity testing. 0.50 mg/mL. |
ExoStd? Lyophilized Exosome Standard (30 µg, SK-N-SH cell line, 4 vials) |
M1056-4 |
Biovision |
|
EUR 1096.8 |
ExoStd? Lyophilized Exosome Standard (100 µg, SK-N-SH cell line, 4 vials) |
M1057-4 |
Biovision |
|
EUR 1370.4 |
Monkey Colon Cancer Specific Antigen-4 (CCSA-4) ELISA Kit |
abx358784-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Rabbit Colon Cancer Specific Antigen-4 (CCSA-4) ELISA Kit |
abx363654-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Pig Colon Cancer Specific Antigen-4 (CCSA-4) ELISA Kit |
abx360753-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human Colon Cancer Specific Antigen 4 (CCSA-4) ELISA Kit |
abx354340-96tests |
Abbexa |
96 tests |
EUR 848.4 |
|
Chicken Colon Cancer Specific Antigen-4 (CCSA-4) ELISA Kit |
abx355731-96tests |
Abbexa |
96 tests |
EUR 990 |
|
Human colon cancer-specific antigen-4,CCSA-4 ELISA kit |
201-12-1665 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human colon cancer-specific antigen-4(CCSA-4)ELISA Kit |
GA-E1681HM-48T |
GenAsia Biotech |
48T |
EUR 346.8 |
Human colon cancer-specific antigen-4(CCSA-4)ELISA Kit |
GA-E1681HM-96T |
GenAsia Biotech |
96T |
EUR 559.2 |
Human colon cancer-specific antigen-4(CCSA-4)ELISA Kit |
QY-E03945 |
Qayee Biotechnology |
96T |
EUR 433.2 |
Prostate Specific Antigen Std Grade Antigen |
VAng-Cr3891-1mg |
Creative Biolabs |
1 mg |
EUR 604.8 |
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation. |
CEA Antigen Grade Protein |
abx060976-05mg |
Abbexa |
0.5 mg |
EUR 1161.6 |
|
CEA Antigen Grade Protein |
abx060977-1mg |
Abbexa |
1 mg |
EUR 2030.4 |
|
Cancer Antigen 125 Antigen (Human Adenocarcinoma) |
VAng-Cr3868-10kU |
Creative Biolabs |
10 kU |
EUR 505.2 |
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography. |
Cancer Antigen 125 Antigen (Ascites Fluid) |
VAng-Cr3870-10kU |
Creative Biolabs |
10 kU |
EUR 1132.8 |
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE. |
Cancer Antigen CEA Antigen (Human Fluids) |
VAng-Wyb8644-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL. |
Human Cancer Antigen CA125 (Ovarian Cancer) Protein |
abx061590-100kU |
Abbexa |
100 kU |
EUR 1446 |
|
ELISA kit for Human CCSA-4 (Colon Cancer Specific Antigen-4) |
E-EL-H0795 |
Elabscience Biotech |
1 plate of 96 wells |
EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human CCSA-4 (Colon Cancer Specific Antigen-4) in samples from Serum, Plasma, Cell supernatant |
ELISA kit for Human Colon cancer-specific antigen-4 (CCSA-4) |
KTE62592-48T |
Abbkine |
48T |
EUR 398.4 |
|
Description: Quantitative sandwich ELISA for measuring Human Colon cancer-specific antigen-4 (CCSA-4) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Colon cancer-specific antigen-4 (CCSA-4) |
KTE62592-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
Description: Quantitative sandwich ELISA for measuring Human Colon cancer-specific antigen-4 (CCSA-4) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Colon cancer-specific antigen-4 (CCSA-4) |
KTE62592-96T |
Abbkine |
96T |
EUR 646.8 |
|
Description: Quantitative sandwich ELISA for measuring Human Colon cancer-specific antigen-4 (CCSA-4) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
Vitamin A Reference Standard (USP grade powder) |
51R-U716002 |
Fitzgerald |
10 pack |
EUR 619.2 |
Description: Vitamin A Reference Standard (USP grade powder) chemical reference substance |
TA(Anti-Trophoblast Membrane Antibody IgM) ELISA test |
72 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of TA(Anti-Trophoblast Membrane Antibody IgM) |
Exo-Check Exosome Antibody Array (Neuro) Standard |
EXORAY500A-4 |
SBI |
4 arrays |
EUR 828 |
Human Cancer OptiTDS1: Tissue Dissociation System |
4-28024 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS2: Tissue Dissociation System |
4-28025 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS3: Tissue Dissociation System |
4-28026 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS4: Tissue Dissociation System |
4-28027 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS5: Tissue Dissociation System |
4-28028 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS6: Tissue Dissociation System |
4-28029 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS7: Tissue Dissociation System |
4-28030 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS8: Tissue Dissociation System |
4-28031 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS9: Tissue Dissociation System |
4-28032 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS10: Tissue Dissociation System |
4-28033 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS11: Tissue Dissociation System |
4-28034 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS12: Tissue Dissociation System |
4-28035 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS13: Tissue Dissociation System |
4-28036 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS14: Tissue Dissociation System |
4-28037 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS15: Tissue Dissociation System |
4-28038 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS16: Tissue Dissociation System |
4-28039 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS18: Tissue Dissociation System |
4-28041 |
CHI Scientific |
1 Kit |
Ask for price |
Human Cancer OptiTDS19: Tissue Dissociation System |
4-28042 |
CHI Scientific |
1 Kit |
Ask for price |
ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen grade |
ODNM362-1 |
Alpha Diagnostics |
1 mg |
EUR 781.2 |
ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen grade |
ODNM362-5 |
Alpha Diagnostics |
5 mg |
EUR 2389.2 |
Ck-Mm Antigen Grade Protein |
abx060710-1mg |
Abbexa |
1 mg |
EUR 777.6 |
|
Human AFP Antigen Grade Protein |
abx060957-1mg |
Abbexa |
1 mg |
EUR 1111.2 |
|
Human AFP Antigen Grade Protein |
abx060958-1mg |
Abbexa |
1 mg |
EUR 1579.2 |
|
Human AFP Antigen Grade Protein |
abx060959-1mg |
Abbexa |
1 mg |
EUR 1195.2 |
|
Human CA125 Antigen Grade Protein |
abx060960-50kU |
Abbexa |
50 kU |
EUR 961.2 |
|
Imidazoquinoline (TLR7 Agonist) Antigen Grade |
VAdv-Ly0018-25mg |
Creative Biolabs |
25 mg |
EUR 4332 |
Description: Imidazoquinoline, a TLR7 agonist vaccine adjuvant. |
Imidazoquinoline (TLR7 Agonist) Antigen Grade |
VAdv-Ly0018-5mg |
Creative Biolabs |
5 mg |
EUR 1033.2 |
Description: Imidazoquinoline, a TLR7 agonist vaccine adjuvant. |
Inactivated ADV Grade 2 Antigen |
VAng-Lsx0003-1mL |
Creative Biolabs |
1 mL |
EUR 1197.6 |
Description: ADV Grade 2, natural antigen. |
Inactivated CMV Grade 2 Antigen |
VAng-Lsx0037-1mg |
Creative Biolabs |
1 mg |
EUR 2432.4 |
Description: CMV Grade 2, natural protein. |
Inactivated CMV Grade 3 Antigen |
VAng-Lsx0038-1mg |
Creative Biolabs |
1 mg |
EUR 2503.2 |
Description: CMV Grade 3, natural protein. |
Inactivated VZV Grade 2 Antigen |
VAng-Lsx0555-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: VZV Grade 2, native virus. |
Inactivated MuV Grade 2 Antigen |
VAng-Lsx0409-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: MuV Grade 2, native virus. |
Inactivated MuV Grade 3 Antigen |
VAng-Lsx0411-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: MuV grade 3, native protein. |
Inactivated Rotavirus Grade 3 Antigen |
VAng-Lsx0469-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Rotavirus Grade 3, native virus. |
Inactivated RuV Grade 2 Antigen |
VAng-Lsx0475-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: RuV Grade 2, natural protein. |
Inactivated RuV Grade 3 Antigen |
VAng-Lsx0476-1mL |
Creative Biolabs |
1 mL |
EUR 474 |
Description: RuV Grade 3, natural protein. |
Inactivated MeV Grade 2 Antigen |
VAng-Lsx0384-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Measles Grade 2, native virus. |
Recombinant CEA Protein (Antigen Grade) |
VAng-Wyb8647-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Carcinoembryonic Antigen, Antigen Grade, recombinant protein from Cell Culture, 3.71 mg/mL. |
CA 72-4 protein |
30C-CP1065S |
Fitzgerald |
25 KU |
EUR 392.4 |
Description: Highly purified Human CA 72-4 protein |
CA 72-4 Protein |
30C-CP1065S2 |
Fitzgerald |
50 KU |
EUR 822 |
Description: Highly purified Human CA 72-4 protein |
CA 72-4 protein |
30-1069 |
Fitzgerald |
1 kU |
EUR 148.8 |
Description: Purified native Human CA 72-4 protein |
CA 72-4 protein |
30-AC23 |
Fitzgerald |
50 KU |
EUR 376.8 |
Description: Purified native Human CA 72-4 protein |
CA 72-4 protein |
30-AC24 |
Fitzgerald |
50 KU |
EUR 468 |
Description: Purified native Human CA 72-4 protein |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
4-RPJ316Hu01 |
Cloud-Clone |
-
EUR 588.79
-
EUR 280.80
-
EUR 1877.95
-
EUR 705.98
-
EUR 1291.97
-
EUR 469.20
-
EUR 4514.88
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Cancer/Testis Antigen 1B expressed in: E.coli |
Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%) |
VAng-Cr3869-25kU |
Creative Biolabs |
25 kU |
EUR 967.2 |
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186. |
Cancer Antigen 19-9 Antigen (Liver Carcinoma) |
VAng-Cr3873-10kU |
Creative Biolabs |
10 kU |
EUR 472.8 |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
Cancer Antigen AFP Antigen (Human Cord Blood) |
VAng-Wyb8624-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Alpha Fetoprotein (66 kDa), Cancer antigen from Human Cord Blood, 1.73 mg/mL. |
Cancer Antigen AFP Antigen (Human hepatocellular carcinoma) |
VAng-Wyb8625-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Alpha Fetoprotein, Antigen Grade, Cancer antigen from human hepatocellular carcinoma, 2.93 mg/mL. |
Cancer Antigen CA-125 Antigen (Human Fluids) |
VAng-Wyb8639-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: CA-125, Calibrator Grade, cancer antigen from Human Fluids, 53.26 KU/mL. |
Cancer Antigen CA-125 Antigen (Human Adenocarcinoma) |
VAng-Wyb8642-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL. |
Cancer Antigen CEA Antigen (Human Metastatic Liver) |
VAng-Wyb8645-inquire |
Creative Biolabs |
inquire |
Ask for price |
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL. |
Recombinant Human IL-8 (72 a.a.) (CXCL8) Protein |
PROTP10145-4 |
BosterBio |
25ug |
EUR 380.4 |
Description: IL-8 is a proinflammatory CXC chemokine that can signal through the CXCR1 and CXCR2 receptors. It is secreted by monocytes and endothelial cells. IL-8 chemoattracts and activates neutrophils. Recombinant human IL-8 (monocyte-derived) is an 8.4 kDa protein containing 72 amino acid residues. |
Recombinant Human HCC-1 (CCL14) (72 a.a.) Protein |
PROTQ16627-4 |
BosterBio |
10ug |
EUR 380.4 |
Description: HCC-1 is a CC chemokine that signals through the CCR1 receptor and chemoattracts blood monocytes. It is secreted by various tissues including skeletal muscle, heart, spleen, liver and bone marrow. Recombinant human HCC-1 is an 8.4 kDa protein consisting of 72 amino acids including the four highly conserved residues present in CC chemokines. |
Standard grade heat shock BSA powder, pH 7 |
BAH62-0050 |
Equitech |
50gm |
EUR 308.88 |
|
Standard grade heat shock BSA powder, pH 7 |
BAH62-0100 |
Equitech |
100gm |
EUR 388.44 |
|
Standard grade heat shock BSA powder, pH 7 |
BAH62-0500 |
Equitech |
500gm |
EUR 511.68 |
|
Standard grade heat shock BSA powder, pH 7 |
BAH62-1000 |
Equitech |
1KG |
Ask for price |
|
Standard grade heat shock BSA powder, pH 7 |
BAH62-10000 |
Equitech |
10KG |
Ask for price |
|
Standard grade heat shock BSA powder, pH 5.2 |
BAH63-0050 |
Equitech |
50gm |
EUR 308.88 |
|
Standard grade heat shock BSA powder, pH 5.2 |
BAH63-0100 |
Equitech |
100gm |
EUR 388.44 |
|
Standard grade heat shock BSA powder, pH 5.2 |
BAH63-0500 |
Equitech |
500gm |
EUR 511.68 |
|
Standard grade heat shock BSA powder, pH 5.2 |
BAH63-1000 |
Equitech |
1KG |
Ask for price |
|
Standard grade heat shock BSA powder, pH 5.2 |
BAH63-10000 |
Equitech |
10KG |
Ask for price |
|
CA199 (Cancer antigen) ELISA test |
13 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA199 (Cancer antigen) |
CA153 (Cancer antigen) ELISA test |
12 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA153 (Cancer antigen) |
CA125 (Cancer antigen) ELISA test |
11 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA125 (Cancer antigen) |
CA50 (Cancer antigen) ELISA test |
10 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CA50 (Cancer antigen) |
Cancer Antigen CA19-9 Antibody |
abx020532-1mg |
Abbexa |
1 mg |
EUR 1296 |
|
Cancer Antigen CA19-9 Antibody |
abx020533-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
Cancer Antigen CA19-9 Antibody |
abx020534-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
Cancer Antigen CA19-9 Antibody |
abx020535-1mg |
Abbexa |
1 mg |
EUR 718.8 |
|
CEA (Cancer antigen) ELISA test |
9 |
Biobase |
96T/Box |
Ask for price |
|
Description: ELISA based test for quantitative detection of CEA (Cancer antigen) |
Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%) |
VAng-Cr3875-25kU |
Creative Biolabs |
25 kU |
EUR 885.6 |
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is> 90% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2. |
Paraffin Tissue Section - Human Bone Tumor: Chondrosarcoma, Grade I - II |
T2235023-4 |
Biochain |
5 slides |
EUR 308.4 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Human CA19-9 Antigen Grade Protein |
abx060967-250kU |
Abbexa |
250 kU |
EUR 1111.2 |
|
Human CA19-9 Antigen Grade Protein |
abx060968-50kU |
Abbexa |
50 kU |
EUR 1378.8 |
|
The combination of anti-EGFR, HER2 and HER3 antibodies is an efficient candidate therapeutic strategy for gemcitabine-sensitive and -resistant pancreatic most cancers. At three months, bodily and function perform scores in addition to signs of fatigue, constipation, and digestive difficulties worsened considerably. Most indices recovered after 1 yr, however poorer bodily perform scores, digestive difficulties, and altered bowel habits endured. Right here we describe a SNP panel for Brazilian pancreatic most cancers, along with medical and epidemiological information.